Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53
The American Journal of Pathology · 2025
DOI: 10.1016/j.ajpath.2024.09.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2025. Verfasst von Thaís Moré Milan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão…. Hauptthemen laut MEDLINE: MicroRNAs, Tumor Suppressor Protein p53, Phosphotransferases (Alcohol Group Acceptor), Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Coordination of Higher Education Personnel Improvement, State of Sao Paulo Research Foundation.
Abstract (Originalsprache)
Alterations in miRNAs, p53, and sphingolipid metabolism are associated with head and neck squamous cell carcinoma (HNSCC). However, the role of sphingosine kinase (SK)-2, an enzyme crucial for sphingolipid metabolism, is poorly understood in HNSCC. The aim of this study was to investigate how SK2 and p53 interact to regulate miRNAs miR-205 and miR-296. Analysis of small-RNA sequencing data from nontumor oral keratinocytes with SK2 overexpression (NOK-SK2) compared to controls (NOK-Ø) revealed differential expression of >100 miRNAs being half-regulated by p53. The expression of miR-205 was down-regulated, and miR-296 was up-regulated, in NOK-SK2 cells; however, cells with SK2 knockdown and p53 overexpression showed an opposite profile. Proteins involved in miRNA biogenesis were increased in NOK-SK2 cells, while levels were decreased in NOK-SK2 cells with p53 overexpression. Transfection with miR-205 mimic and miR-296 inhibitor decreased the aggressiveness and the number of cancer stem-like cells in oral keratinocytes and oral carcinoma cells with SK2 regulation. Overexpression of miR-205 in HN12-SK2 cells decreased tumor-formation capacity, and NOK-SK2 cells abrogated tumor growth in mice. The results indicate crosstalk between SK2 and p53 in regulating miRNAs 205 and 296, which could be potential therapeutic targets in the treatment of HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. Electronic address: andreiaml@usp.br.
Förderung
- National Council for Scientific and Technological Development
- Coordination of Higher Education Personnel Improvement
- State of Sao Paulo Research Foundation
Zitieren
APA
Milan, T. M., Silva, G., Sousa, L. O., & Leopoldino, A. M. (2025). Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2024.09.009
Vancouver
Milan TM, Silva G, Sousa LO, Leopoldino AM. Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53. The American Journal of Pathology. 2025. doi:10.1016/j.ajpath.2024.09.009
BibTeX
@article{Milan2025,
author = {Milan, Thaís Moré and Silva, Gabriel and Sousa, Lucas Oliveira and Leopoldino, Andréia Machado},
title = {Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53},
journal = {The American Journal of Pathology},
year = {2025},
doi = {10.1016/j.ajpath.2024.09.009}
}
EUVIMED